Following treatment of anakinra concomitant with induction of CpG-induced hyperinflammation, we examined the main parameters of disease to ascertain the role of IL-1α/β signalling in CpG-induced MAS (Fig. 4A). The gene discussed is IL1A; the disease is macrophage activation syndrome.